| Volume Editors | 5 |
|---|
| Editorial Board | 5 |
|---|
| Topics in Medicinal Chemistry Also Available Electronically | 6 |
|---|
| Preface to the Series | 7 |
|---|
| Preface to Volume 4 | 8 |
|---|
| Contents | 9 |
|---|
| Overview: Transporters as Targets for Drug Discovery | 10 |
|---|
| 1 Introduction | 11 |
| 2 Transporter Classification | 11 |
| 3 NSS Transporter Assays | 14 |
| 4 Transporters and Structure-Based Drug Design (SBDD) | 15 |
| 5 Transporters as Targets for Drug Discovery | 17 |
| 6 Summary | 20 |
| References | 20 |
| Membrane Transporters: Structure, Function and Targets for Drug Design | 23 |
|---|
| 1 Introduction | 25 |
| 2 Membrane Protein Structures | 27 |
| 3 Membrane Transporter Proteins | 28 |
| 4 Structure Determination of Membrane Proteins | 32 |
| 5 Transporters of Known 3D Structure | 37 |
| 6 Potential for New Drug Development | 44 |
| 7 Conclusions | 54 |
| References | 55 |
| Design of Monoamine Reuptake Inhibitors: SSRIs, SNRIs and NRIs | 60 |
|---|
| 1 Introduction | 61 |
| 2 Selective Serotonin Reuptake Inhibitors | 64 |
| 3 Dual Serotonin and Noradrenaline Reuptake Inhibitors | 72 |
| 4 Noradrenaline Reuptake Inhibitors | 87 |
| 5 Conclusions | 98 |
| References | 98 |
| Atypical Dopamine Uptake Inhibitors that Provide Clues About Cocaine s Mechanism at the Dopamine Transporter | 102 |
|---|
| 1 Introduction Chemical and Pharmacological Diversity of Dopamine Uptake Inhibitors | 103 |
| 2 Case Study: Benztropine Analogues | 104 |
| 3 Design, Synthesis and SAR of the Benztropine Analogues | 106 |
| 4 In Vivo Findings | 116 |
| 5 Mechanisms for Differences with Cocaine | 121 |
| 6 Preclinical Assessment of Cocaine-Abuse Therapy | 130 |
| 7 Summary and Conclusions | 133 |
| References | 134 |
| The Design, Synthesis and Structure Activity Relationship of Mixed Serotonin, Norepinephrine and Dopamine Uptake Inhibitors | 137 |
|---|
| 1 Introduction | 138 |
| 2 Overview of Dual-Uptake Inhibitors | 140 |
| 3 Design, Synthesis and Structure Activity Relationship of Triple- Uptake Inhibitors | 143 |
| 4 Conclusions | 157 |
| References | 158 |
| Molecular Imaging of Transporters with Positron Emission Tomography | 161 |
|---|
| 1 Introduction | 163 |
| 2 PET Principles | 164 |
| 3 PET Studies of Transporters | 170 |
| 4 Conclusions | 186 |
| References | 187 |
| Pharmacology of Glutamate Transport in the CNS:Substrates and Inhibitorsof Excitatory Amino Acid Transporters (EAATs)and the Glutamate/Cystine Exchanger System x c | 193 |
|---|
| 1 Introduction | 195 |
| 2 Excitatory Amino Acid Transporters (EAATs) | 196 |
| 3 System x c : Cystine/Glutamate Exchanger | 214 |
| References | 223 |
| Glycine Transporters and Their Inhibitors | 229 |
|---|
| 1 Introduction | 230 |
| 2 Glycine Transporter Isoforms | 230 |
| 3 Distribution | 231 |
| 4 Function | 232 |
| 5 Therapeutic Potential | 233 |
| 6 Medicinal Chemistry of Glycine Transporter Inhibitors | 235 |
| 7 Conclusion | 247 |
| References | 247 |
| Subject Index | 254 |